These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 23777931)
41. Anti-HLA antibody profile of Turkish patients with end-stage renal disease. Karahan GE; Seyhun Y; Oguz F; Kekik C; Onal E; Caliskan Y; Bakkaloglu H; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN Transplant Proc; 2009 Nov; 41(9):3651-4. PubMed ID: 19917361 [TBL] [Abstract][Full Text] [Related]
42. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells. Wilcock LK; Francis JN; Durham SR Clin Exp Allergy; 2004 Sep; 34(9):1373-8. PubMed ID: 15347369 [TBL] [Abstract][Full Text] [Related]
43. Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization. Toyoda M; Pao A; Vo A; Lukovsky M; Radha R; Sado T; Ge S; Reinsmoen N; Chai NN; Baden L; Petrosyan A; Skinner E; Mirocha J; Jordan SC Transpl Immunol; 2010 Feb; 22(3-4):121-7. PubMed ID: 19944759 [TBL] [Abstract][Full Text] [Related]
44. Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization. Kato T; Mizutani K; Terasaki P; Quintini C; Selvaggi G; Thompson J; Ruiz P; Tzakis A Transplant Proc; 2006; 38(6):1735-7. PubMed ID: 16908266 [TBL] [Abstract][Full Text] [Related]
45. Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination. Pauksen K; Sjölin J; Linde A; Alm G; Andersson B; Lönnerholm G; Ljungman P Bone Marrow Transplant; 1997 Aug; 20(4):317-23. PubMed ID: 9285547 [TBL] [Abstract][Full Text] [Related]
46. Kidney transplantation in the United States. Cecka JM Clin Transpl; 2008; ():1-18. PubMed ID: 19711510 [TBL] [Abstract][Full Text] [Related]
47. Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report. Schlaf G; Radam C; Wahle A; Altermann WW Transplant Proc; 2012 Jun; 44(5):1442-5. PubMed ID: 22664032 [TBL] [Abstract][Full Text] [Related]
48. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Lee PC; Zhu L; Terasaki PI; Everly MJ Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641 [TBL] [Abstract][Full Text] [Related]
49. Role of anti-vimentin antibodies in allograft rejection. Rose ML Hum Immunol; 2013 Nov; 74(11):1459-62. PubMed ID: 23777935 [TBL] [Abstract][Full Text] [Related]
50. Cytokine profile of food-allergic post-liver transplant children is identified by high levels of IL-5 and low IL-10 secretion from patients' peripheral blood mononuclear cells. Nahum A; Brener A; Granot E Pediatr Transplant; 2015 Nov; 19(7):716-21. PubMed ID: 26282695 [TBL] [Abstract][Full Text] [Related]
51. Anti-vimentin antibodies in transplant and disease. Divanyan T; Acosta E; Patel D; Constantino D; Lopez-Soler RI Hum Immunol; 2019 Aug; 80(8):602-607. PubMed ID: 30926354 [TBL] [Abstract][Full Text] [Related]
52. Altered Phosphorylation of Cytoskeleton Proteins in Peripheral Blood Mononuclear Cells Characterizes Chronic Antibody-Mediated Rejection in Kidney Transplantation. Rocchetti MT; Rascio F; Castellano G; Fiorentino M; Netti GS; Spadaccino F; Ranieri E; Gallone A; Gesualdo L; Stallone G; Pontrelli P; Grandaliano G Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899575 [TBL] [Abstract][Full Text] [Related]
53. Development of a bead-based immunoassay to routinely measure vimentin autoantibodies in the clinical setting. Fhied C; Kanangat S; Borgia JA J Immunol Methods; 2014 May; 407():9-14. PubMed ID: 24657702 [TBL] [Abstract][Full Text] [Related]
54. [Vaccination in patients with chronic renal failure in the pre- and posttransplantation period]. Goryainov VA; Kaabak MM; Babenko NN; Zokoev AK; Morozova MM; Platova EN; Panin VV; Dymova OV Ter Arkh; 2015; 87(12):32-35. PubMed ID: 26978415 [TBL] [Abstract][Full Text] [Related]
55. Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life. Sullivan JA; Jankowska-Gan E; Hegde S; Pestrak MA; Agashe VV; Park AC; Brown ME; Kernien JF; Wilkes DS; Kaufman DB; Greenspan DS; Burlingham WJ Am J Transplant; 2017 Apr; 17(4):944-956. PubMed ID: 27801552 [TBL] [Abstract][Full Text] [Related]
56. Immunomodulation of endothelial cells induced by macrolide therapy in a model of septic stimulation. Pons S; Arrii E; Arnaud M; Loiselle M; Ferry J; Nouacer M; Lion J; Cohen S; Mooney N; Zafrani L Immun Inflamm Dis; 2021 Dec; 9(4):1656-1669. PubMed ID: 34636179 [TBL] [Abstract][Full Text] [Related]
57. IL-10-specific autoantibodies predict major adverse cardiovascular events in kidney transplanted patients - a retrospective cohort study. Lund KP; von Stemann JH; Eriksson F; Hansen MB; Pedersen BK; Sørensen SS; Bruunsgaard H Transpl Int; 2019 Sep; 32(9):933-948. PubMed ID: 30883970 [TBL] [Abstract][Full Text] [Related]
58. Understanding immunological response to desensitisation strategies in highly sensitised potential kidney transplant patients. May FNJ; Rees MT; Griffin S; Fildes JE Transplant Rev (Orlando); 2021 Apr; 35(2):100596. PubMed ID: 33582579 [TBL] [Abstract][Full Text] [Related]
59. Monitoring of mononuclear cells from arterial and central venous blood in lung transplant patients. Holzinger C; Zuckermann A; Kopp C; Schöllhammer A; Imhof M; Laczkovics A; Klepetko W; Laufer G; Wolner E Transplantation; 1992 Apr; 53(4):935-7. PubMed ID: 1566361 [No Abstract] [Full Text] [Related]
60. A Curious Case of Anti-Human Leukocyte Antigen-Bw4 Antibody in a Kidney Transplant Candidate. Ibrahim MM; Shen M; Merzkani M; Liu C J Appl Lab Med; 2023 Nov; 8(6):1178-1183. PubMed ID: 37610416 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]